Profile
| Metric | Value |
|---|---|
| Full Name | Calumet, Inc. |
| Ticker | NASDAQ: CLMT |
| Exchange | NASDAQ |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | calumet.com |
| Employees | 1,620 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $19.87 | |
| Price, 1D Change | -1.29% | |
| Market Cap | $2B | |
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | 1.36 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +0.20% | |
| EPS | -$2.67 | |
| EPS, 1Y Change | -553.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.69 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.67 | |
| EPS Estimate | -$0.15 | |
| EPS Est. Change | +94.38% | |
| Revenue | $4.19B | |
| Revenue Estimate | $4.19B | |
| Revenue Est. Change | -0.08% | |
| Current Price | $19.87 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +0.65% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.03 | $0.59 | -42.89% | |
| -$2.30 | -$2.67 | -15.84% | |
| -$0.15 | N/A | +94.38% | |
| $0.03 | N/A | +101.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.13B | $4.18B | +1.23% | |
| $4.16B | $4.19B | +0.66% | |
| $4.19B | N/A | -0.08% | |
| $4.25B | N/A | +1.36% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -7.06% | |
| Price, 3Y | +17.78% | |
| Market Cap, 1Y | -6.19% | |
| Market Cap, 3Y | +29.03% | |
| Revenue, 1Y | +0.20% | |
| Revenue, 3Y | +33.08% | |
| EPS, 1Y | -553.93% | |
| EPS, 3Y | +17.27% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $19.87 | |
| SMA 200 | $16.21 | |
| SMA 200 vs Price | -18.40% | |
| SMA 50 | $19.47 | |
| SMA 50 vs Price | -2.02% | |
| Beta | 1.36 | |
| ATR | $0.67 | |
| 14-Day RSI | 53.34 | |
| 10-Day Volatility | 16.12% | |
| 1-Year Volatility | 60.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.69 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.19B | |
| EPS | -$2.67 | |
| Gross Profit | $230.80M | |
| Gross Margin | 5.51% | |
| Operating Profit | $10.10M | |
| Operating Margin | 0.24% | |
| Net Income | -$222.00M | |
| Net Margin | -5.30% | |
| EBITDA | $164.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -3.33 | |
| Current Ratio | 0.89 | |
| Quick Ratio | 0.40 | |
| - | ||
| F-Score | 2 | |
| Altman Z-Score | 1.03 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.43 | |
| PB Ratio | -2.48 | |
| EV/EBITDA | 11.38 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$704.90M | |
| Cash & Equivalents | $45.90M | |
| Total Assets | $2.76B | |
| Current Assets | $766.00M | |
| Total Liabilities | $3.22B | |
| Current Liabilities | $863.60M | |
| Total Debt | $2.37B | |
| Short Term Debt | $126.30M | |
| Accounts Payable | $320.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $4.18B | |
| Operating Expenses | $220.70M | |
| Cost Of Goods Sold | $3.96B | |
| SG&A | $201.20M | |
| D&A | $187.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $800.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$46.40M | |
| CFI | -$76.70M | |
| CFF | $154.30M | |
| Capex | $76.70M | |
| Free Cash Flow | -$123.10M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| UBS | → | |
| Wells Fargo | → | |
| B of A Securities | ||
| Goldman Sachs | → | |
| Wells Fargo | → | |
| UBS | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CLMT
Data Sources & References
- CLMT Official Website calumet.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2013745/000201374525000017/0002013745-25-000017-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2013745/000155837025001961/0001558370-25-001961-index.htm
- CLMT Profile on Yahoo Finance finance.yahoo.com/quote/CLMT
- CLMT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clmt
FAQ
What is the ticker symbol for Calumet, Inc.?
The ticker symbol for Calumet, Inc. is NASDAQ:CLMT
Does Calumet, Inc. pay dividends?
No, Calumet, Inc. does not pay dividends
What sector is Calumet, Inc. in?
Calumet, Inc. is in the Basic Materials sector
What industry is Calumet, Inc. in?
Calumet, Inc. is in the Specialty Chemicals industry
What country is Calumet, Inc. based in?
Calumet, Inc. is headquartered in United States
When did Calumet, Inc. go public?
Calumet, Inc. initial public offering (IPO) was on January 26, 2006
Is Calumet, Inc. in the S&P 500?
No, Calumet, Inc. is not included in the S&P 500 index
Is Calumet, Inc. in the NASDAQ 100?
No, Calumet, Inc. is not included in the NASDAQ 100 index
Is Calumet, Inc. in the Dow Jones?
No, Calumet, Inc. is not included in the Dow Jones index
When was Calumet, Inc. last earnings report?
Calumet, Inc.'s most recent earnings report was on November 7, 2025
When does Calumet, Inc. report earnings?
The next expected earnings date for Calumet, Inc. is February 27, 2026